XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition (Tables)
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Contract Assets and Liabilities
The following table summarizes the values of contract assets, capitalized commissions, and contract liabilities for Advanced Diagnostics as of December 31, 2023 and 2022 (in thousands):
20232022
Current contract assets(1)
$37 $1,898 
Long-term contract assets(2)
— 31 
Total contract assets$37 $1,929 
Current capitalized commissions(1)
$935 $800 
Long-term capitalized commissions(2)
53 715 
Total capitalized commissions$988 $1,515 
Current contract liabilities$2,130 $7,557 
Long-term contract liabilities(3)
— 19 
Total contract liabilities$2,130 $7,576 
(1) Recorded within other current assets on the Consolidated Balance Sheets.
(2) Recorded within other assets on the Consolidated Balance Sheets.
(3) Recorded within other long-term liabilities on the Consolidated Balance Sheets.
Schedule of Disaggregation of Revenue
The following table details the disaggregation of net revenue for both the Clinical Services and Advanced Diagnostics Segments for the years ended December 31, 2023, 2022 and 2021 (in thousands):
202320222021
Clinical Services:
    Client direct billing$332,894 $279,732 $252,617 
    Commercial insurance88,022 73,280 78,773 
    Medicare and other government74,370 65,585 72,010 
    Self-pay350 157 772 
Total Clinical Services495,636 418,754 404,172 
Advanced Diagnostics96,007 90,974 80,157 
Total net revenue$591,643 $509,728 $484,329